| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.22 | 0.07 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.07 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |